Dihematoporphyrin ether
Dihematoporphyrin ether Brand names, Dihematoporphyrin ether Analogs
Dihematoporphyrin ether Brand Names Mixture
- No information avaliable
Dihematoporphyrin ether Chemical_Formula
C68H74N8O11
Dihematoporphyrin ether RX_link
http://www.rxlist.com/cgi/generic3/photofrin.htm
Dihematoporphyrin ether fda sheet
Dihematoporphyrin ether msds (material safety sheet)
Dihematoporphyrin ether Synthesis Reference
No information avaliable
Dihematoporphyrin ether Molecular Weight
1179.36 g/mol
Dihematoporphyrin ether Melting Point
No information avaliable
Dihematoporphyrin ether H2O Solubility
No information avaliable
Dihematoporphyrin ether State
Solid
Dihematoporphyrin ether LogP
5.127
Dihematoporphyrin ether Dosage Forms
Powder for solution
Dihematoporphyrin ether Indication
Indicated in the treatment of esophageal cancer.
Dihematoporphyrin ether Pharmacology
Porfimer is a photosensitizing agent used in the photodynamic therapy (PDT) of tumors. Porfimer is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who cannot be satisfactorily treated with Nd:YAG laser therapy, reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nonsmall cell lung cancer (NSCLC), and the treatment of microinvasive endobronchial NSCLC in patients for whom surgery and radiotherapy are not indicated. The cytotoxic and antitumor actions of porfimer are light and oxygen dependent. Tumor selectivity in treatment occurs through a combination of selective retention of porfimer and selective delivery of light.
Dihematoporphyrin ether Absorption
No information avaliable
Dihematoporphyrin ether side effects and Toxicity
No information avaliable
Dihematoporphyrin ether Patient Information
No information avaliable
Dihematoporphyrin ether Organisms Affected
Humans and other mammals
